Pharmacokinetics and Safety of Single-Dose Wafermine™ (Ketamine Sublingual Wafer) in Healthy Subjects

Clinical trial NCT07691372 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07691372
Sponsor: iX Biopharma Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Participants

Start date: 2026-06-09
Primary completion: 2026-07-17
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.